======= VPS52 ======= == Gene Information == * **Official Symbol**: VPS52 * **Official Name**: VPS52 subunit of GARP complex * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=6293|6293]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8N1B4|Q8N1B4]] * **Interactions**: [[https://thebiogrid.org/search.php?search=VPS52&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20VPS52|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603443|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |Sec3| |Vps52| |embryonic ectodermal digestive tract development| |ectodermal digestive tract development| |GARP complex| |EARP complex| |ectodermal cell differentiation| |Golgi to vacuole transport| |ectoderm development| |embryonic digestive tract development| |endocytic recycling| |syntaxin binding| |retrograde transport, endosome to Golgi| |trans-Golgi network membrane| |post-Golgi vesicle-mediated transport| |lysosomal transport| |recycling endosome| |digestive tract development| |vacuolar transport| |digestive system development| |cytosolic transport| |Rab GTPase binding| |endosome membrane| |endosomal transport| |Golgi vesicle transport| |embryonic organ development| |tissue morphogenesis| |perinuclear region of cytoplasm| |tube development| |embryo development| |Golgi apparatus| |protein transport| |intracellular transport| |peptide transport| |amide transport| |establishment of protein localization| |tissue development| |establishment of localization in cell| |nitrogen compound transport| |vesicle-mediated transport| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp539|42°C R08 exp539]]|-3.3| |[[:results:exp7|Bortezomib 0.05μM R00 exp7]]|-2.45| |[[:results:exp22|MLN-4924 2μM R00 exp22]]|-2.45| |[[:results:exp457|Bisphenol F 50μM R08 exp457]]|-2.22| |[[:results:exp108|Vinblastine 0.2μM R03 exp108]]|-2.1| |[[:results:exp487|Hinokiflavone 12μM R08 exp487]]|-2.09| |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|-2.07| |[[:results:exp455|Benzoate 10000μM R08 exp455]]|-2.06| |[[:results:exp19|Etoposide 1μM R00 exp19]]|-2.06| |[[:results:exp282|Fluvastatin 2.2μM R06 exp282]]|-2.06| |[[:results:exp2|5-Fluorouracil 20μM R00 exp2]]|-2| |[[:results:exp17|DABN 20μM R00 exp17]]|-1.96| |[[:results:exp506|Momordin-Ic 10μM R08 exp506]]|-1.93| |[[:results:exp90|WYE-354 6μM R02 exp90]]|-1.9| |[[:results:exp20|Etoposide 10μM R00 exp20]]|-1.88| |[[:results:exp34|Rotenone 20μM R00 exp34]]|-1.88| |[[:results:exp269|Bisphenol A 100μM R06 exp269]]|-1.77| |[[:results:exp526|Sulforaphane 9μM R08 exp526 no dilution day6]]|-1.77| |[[:results:exp533|TNF-alpha 44ng/ml R08 exp533]]|-1.77| |[[:results:exp469|CFI-400945 25μM R08 exp469]]|-1.74| |[[:results:exp26|Oligomycin-A 20μM R00 exp26]]|-1.73| |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|-1.72| |[[:results:exp162|BI-D1870 2μM R04 exp162]]|1.7| |[[:results:exp229|Dimethyloxaloylglycine 100μM R05 exp229]]|1.82| ^Gene^Correlation^ |[[:human genes:p:polr2j3|POLR2J3]]|0.559| |[[:human genes:c:copb2|COPB2]]|0.491| |[[:human genes:v:vps54|VPS54]]|0.49| |[[:human genes:c:copa|COPA]]|0.473| |[[:human genes:v:vps51|VPS51]]|0.469| |[[:human genes:c:copz1|COPZ1]]|0.462| |[[:human genes:a:atp6v1a|ATP6V1A]]|0.456| |[[:human genes:t:tssc1|TSSC1]]|0.446| |[[:human genes:p:pola1|POLA1]]|0.444| |[[:human genes:t:trappc11|TRAPPC11]]|0.443| |[[:human genes:m:med14|MED14]]|0.442| |[[:human genes:t:tbc1d3h|TBC1D3H]]|0.441| |[[:human genes:c:copg1|COPG1]]|0.438| |[[:human genes:s:sys1|SYS1]]|0.438| |[[:human genes:a:atp6v0b|ATP6V0B]]|0.436| |[[:human genes:s:slc6a17|SLC6A17]]|0.434| |[[:human genes:c:chd4|CHD4]]|0.433| |[[:human genes:p:polr2d|POLR2D]]|0.429| |[[:human genes:s:strn|STRN]]|0.427| |[[:human genes:t:trappc8|TRAPPC8]]|0.426| |[[:human genes:y:ythdc1|YTHDC1]]|0.425| |[[:human genes:t:tbc1d3f|TBC1D3F]]|0.424| |[[:human genes:p:prim1|PRIM1]]|0.423| |[[:human genes:u:utp3|UTP3]]|0.421| |[[:human genes:t:tceb3cl2|TCEB3CL2]]|0.421| |[[:human genes:z:znf830|ZNF830]]|0.42| |[[:human genes:u:upf1|UPF1]]|0.419| |[[:human genes:t:tbc1d3g|TBC1D3G]]|0.418| |[[:human genes:a:atp6v0c|ATP6V0C]]|0.416| |[[:human genes:a:arcn1|ARCN1]]|0.415| |[[:human genes:s:supt6h|SUPT6H]]|0.411| |[[:human genes:o:ogdh|OGDH]]|0.409| |[[:human genes:p:psmb2|PSMB2]]|0.406| |[[:human genes:s:slc4a1|SLC4A1]]|0.406| |[[:human genes:t:tceb3cl|TCEB3CL]]|0.403| |[[:human genes:m:myb|MYB]]|0.403| |[[:human genes:c:ccna2|CCNA2]]|0.402| |[[:human genes:d:ddtl|DDTL]]|0.401| |[[:human genes:s:slc38a7|SLC38A7]]|0.401| Global Fraction of Cell Lines Where Essential: 6/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|1/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|1/16| |kidney|0/21| |liver|0/20| |lung|2/75| |lymphocyte|0/16| |ovary|1/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|1/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 85 * **Expression level (log2 read counts)**: 5.99 {{:chemogenomics:nalm6 dist.png?nolink |}}